NDAORALTABLET, ORALLY DISINTEGRATING
Approved
Jun 1998
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Mechanism of Action
5-HT 1B/1D receptors. MAXALT presumably exerts its therapeutic effects in the treatment of migraine headache by binding to 5-HT 1B/1D receptors located on intracranial blood vessels and sensory nerves of the trigeminal system.